missing translation for 'onlineSavingsMsg'
Learn More

Chromogranin A / CHGA (Neuroendocrine Marker) Mouse, Clone: rCHGA/798, enQuireBio™

Mouse Monoclonal Antibody

2050.00 SEK - 5965.00 SEK

Specifications

Antigen Chromogranin A / CHGA (Neuroendocrine Marker)
Clone rCHGA/798
Concentration 200ÎĽg/mL
Applications Immunohistochemistry
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
15979777
View Documents
EnquireBio
1113-MSM17-P0
20 ÎĽg This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
N/A
15989777
View Documents
EnquireBio
1113-MSM17-P1
100 ÎĽg
5965.00 SEK
100µg
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Specifications

Specifications

Chromogranin A / CHGA (Neuroendocrine Marker)
200ÎĽg/mL
Monoclonal
Mouse
10mM PBS with 0.05% BSA and 0.05% azide. Also available without BSA and Azide.
Recombinant full-length human CHGA protein
Primary
Short term: Store at 2-4°C. Long term, aliquot and store at -20°C.
68-75kDa
rCHGA/798
Immunohistochemistry
Unconjugated
RUO
1113
IgG1 Îş
Protein A/G purified from Bioreactor concentrate.
Finely granular cytoplasmic
PC12 cells. Adrenal gland, bowel, thyroid, pancreas, or pheochromocytoma.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title
Chromogranin A / CHGA (Neuroendocrine Marker) Mouse, Clone: rCHGA/798, enQuireBio™

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.